Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video] Why Is the Drug Industry in a Deal Frenzy?
Bloomberg
Thursday, April 24, 2014 - 7:31am
tags:
M&A, Novartis, Valeant Pharmaceuticals, GSK, Eli Lilly, Allergan
Expired Patents Take a Bite out of Eli Lilly Results
Yahoo/247WallStreet
Thursday, April 24, 2014 - 7:26am
tags:
Eli Lilly, earnings
AstraZeneca CEO: M&A 'often disruptive;' company posts higher revenues, but declining profits
CNBC
Thursday, April 24, 2014 - 7:19am
tags:
Pharma CEOs, Pfizer, Pascal Soriot, M&A, earnings, AstraZeneca
4 Pharmaceuticals With Significant Potential
Seeking Alpha
Thursday, April 24, 2014 - 7:17am
tags:
Pfizer, Sanofi, Ampio Pharmaceuticals, Rafarma Pharmaceuticals, Russia
Novartis sales miss forecast as readies overhaul
Yahoo/Reuters
Thursday, April 24, 2014 - 7:15am
tags:
earnings, Novartis
Big Pharma sees danger, not safety, in FDA's new social media guidance
Fierce Pharma Marketing
Wednesday, April 23, 2014 - 5:39pm
tags:
social media, FDA
Stryker 1st-quarter net profit falls 77 pct as costs increase
Yahoo/Reuters
Wednesday, April 23, 2014 - 5:29pm
tags:
Stryker, devices, earnings
Amedisys to Pay $150 Million for Medicare False Billing
Bloomberg
Wednesday, April 23, 2014 - 5:28pm
tags:
Medicare, False Claims Act, home health, Amedisys
Intuitive Surgical Plunges On Weak Sales Of Da Vinci Systems
Yahoo/Benzinga
Wednesday, April 23, 2014 - 5:23pm
tags:
earnings, Intuitive Surgical, devices
Earnings Preview: Eli Lilly guidance may be in focus after acquisitions
The Fly on the Wall
Wednesday, April 23, 2014 - 3:05pm
tags:
earnings, Eli Lilly
Allergan poison pill presages a battle against Valeant's $47B takeover
Fierce Pharma
Wednesday, April 23, 2014 - 12:48pm
tags:
poison pill, Valeant Pharmaceuticals, M&A
Say Hello to the New Fastest Growing Drug in History!
Motley Fool
Wednesday, April 23, 2014 - 12:36pm
tags:
Gilead Sciences, Sovaldi, hepatitis C, drug launches
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
Fierce Pharma
Wednesday, April 23, 2014 - 12:02pm
tags:
breast cancer, Roche, NICE, Kadcyla, HER2-positive metastatic breast cancer
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wednesday, April 23, 2014 - 11:57am
tags:
Juxtapid, Otezla, Aegerion, Celgene, GW Pharma, Sativex, Intercept Pharma, OCA, Ironwood Pharmaceuticals, Linzess, Lpath, iSONEP, MannKind, Afrezza, Xtandi, H.P. Acthar Gel, Questcor Pharmaceuticals, eteplirsen, Sarepta Therapeutics
Should Amgen Break Itself Up?
Forbes
Wednesday, April 23, 2014 - 10:56am
tags:
Amgen
Today's Health Care Stocks to Watch: Illumina Inc., Intuitive Surgical Inc. and Gilead Sciences
Motley Fool
Wednesday, April 23, 2014 - 10:41am
tags:
Illumina, Intuitive Surgical, earnings, devices, Gilead Sciences
Why Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan
Motley Fool
Wednesday, April 23, 2014 - 10:34am
tags:
Valeant Pharmaceuticals, Allergan, M&A, medical aesthetics
Alnylam Strikes Back: Comments From CEO John Maraganore
Forbes
Wednesday, April 23, 2014 - 10:19am
tags:
Pharma CEOs, John Maraganore, Alnylam, RNAi
Gilead: X-Marks The Spot For Sovaldi Sales
Seeking Alpha
Wednesday, April 23, 2014 - 10:18am
tags:
Gilead Sciences, Sovaldi, hepatitis C, Incyte, Clovis Oncology, Puma Biotechnology
Earnings Roundup: Baxter International Grows Ahead of Its Spin-Off
Motley Fool
Wednesday, April 23, 2014 - 9:46am
tags:
Baxter International, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.